Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7026 - 7050 of 13643 in total

Digitoxigenin

Digitoxigenin is a cardenolide which is the aglycon of digitoxin.
Experimental
Matched Iupac: … 4-[(1R,3aS,3bR,5aR,7S,9aS,9bS,11aR)-3a,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren …
Matched Description: … Digitoxigenin is a cardenolide which is the aglycon of digitoxin. …

Anetumab ravtansine

Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).
Investigational
Matched Description: … in Treating Participants With Advanced Non-small Cell Lung Cancer). ... Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab …

Lanraplenib

Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
Investigational
Matched Iupac: … 6-[8-({4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]pyrazin-2-amine …
Matched Description: … Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)). ... Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and …

Virus Specific T-Cell

Virus Specific T-Cells (VSTs) are a target therapy that are generated for specific viral antigens. These products are generated from virus-naive or virus-experienced autologous or allogenic sources. Antigens identified as an immune target are presented by antigen-presenting cells (APCs) to T-cells along with other molecules that stimulate their growth and...
Investigational
Matched Description: … Virus Specific T-Cells (VSTs) are a target therapy that are generated for specific viral antigens. ... These T-cells are then isolated from the donor and expanded in a culture to generate more VSTs. ... In some cases, the cells are created from blood samples of patients who have recovered from viral infections …

Cathine

Cathine, also known as d-norpseudoephedrine and (+)-norpseudoephedrine, is a psychoactive drug with stimulant properties. It belongs to the phenethylamine and amphetamine chemical classes. In the United States, it is classified as a Schedule IV controlled substance.
Experimental
Illicit
Matched Description: … In the United States, it is classified as a Schedule IV controlled substance. ... Cathine, also known as d-norpseudoephedrine and (+)-norpseudoephedrine, is a psychoactive drug with stimulant …

Sirpiglenastat

Sirpiglenastat, also known as DRP-104, is a prodrug of 6-diazo-5-oxo-L-norleucine (DON), which is a broad-acting glutamine antagonist. It is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With Advanced Solid Tumors).
Investigational
Matched Description: … Sirpiglenastat, also known as DRP-104, is a prodrug of [6-diazo-5-oxo-L-norleucine] (DON), which is a ... It is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With …

Bucillamine

Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.
Investigational
Matched Description: … Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis …
Matched Categories: … Compounds used in a research, industrial, or household setting …

Aspacytarabine

Investigational

HH-009

HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment of hepatocellular carcinoma.
Investigational
Matched Description: … HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment …

Iron (III) oxide adipate

Investigational

(S)-Mandelic acid

Experimental

N-Acetylmethionine

Experimental

KP-1461

KP-1461 is a potent, non-chain-terminating, mutagenic deoxyribonucleoside analogue. Designated a DNA covert nucleoside, the drug consists of a modified base that incorporates randomly into HIV and pairs with multiple bases.
Investigational
Matched Description: … Designated a DNA covert nucleoside, the drug consists of a modified base that incorporates randomly into ... KP-1461 is a potent, non-chain-terminating, mutagenic deoxyribonucleoside analogue. …

MDX-1303

MDX-1303 is a fully human antibody against the inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium, and targets a protein component of these lethal toxins known as the anthrax protective antigen.
Investigational
Matched Description: … MDX-1303 is a fully human antibody against the inhalation anthrax, the most lethal form of illness in ... humans caused by the Bacillus anthracis bacterium, and targets a protein component of these lethal toxins …

Bintrafusp alfa

Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)).
Investigational
Matched Description: … Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced …

Alagebrium

Alagebrium has been investigated for the treatment and prevention of Aging, Heart Failure, Physical Activity, Diabetic Nephropathy, and Cardiovascular Disease, among others.
Investigational
Matched Description: … Alagebrium has been investigated for the treatment and prevention of Aging, Heart Failure, Physical Activity …

Tengonermin

Tengonermin, also known as NGR-hTNF, is a vascular-targeting drug. It is a recombinant protein and peptide-targeted agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. This drug works by modifying the tumor microenvironment and increasing intratumoral chemotherapy penetration and T-cell infiltration. NGR-hTNF specifically targets angiogenic...
Investigational
Matched Description: … of NGR-hTNF to tumor vessels and the increase in its antiangiogenic activity. ... Tengonermin, also known as NGR-hTNF, is a vascular-targeting drug. ... [A233265] It is a recombinant protein and peptide-targeted agent consisting of the human Tumour Necrosis …

MCMV3068A

MCMV3068A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with MCMV5322A to form RG7667.
Investigational
Matched Description: … MCMV3068A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with [MCMV5322A] to …

RLYB212

RLYB212 is a human monoclonal antibody against Antigen-1A Immunoglobulin (HPA-1A). It is currently being developed by Rallybio for the prevention of fetal and neonatal alloimmune thrombocytopenia.
Investigational
Matched Description: … RLYB212 is a human monoclonal antibody against Antigen-1A Immunoglobulin (HPA-1A). ... It is currently being developed by Rallybio for the prevention of fetal and neonatal alloimmune thrombocytopenia …

Samuraciclib

Samuraciclib is under investigation in clinical trial NCT03363893 (Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies).
Investigational
Matched Iupac: … (3R,4R)-4-({[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}methyl)piperidin-3-ol …
Matched Description: … in Cancer Patients With Advanced Malignancies). ... Samuraciclib is under investigation in clinical trial NCT03363893 (Modular Study to Evaluate CT7001 Alone …

Palmidrol

A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Palmidrol is available for human use as a supplement (400 mg capsules) and as food for medical purposes In Italy and Spain (300 mg and 600 mg tablets).
Experimental
Nutraceutical
Matched Description: … Palmidrol is available for human use as a supplement (400 mg capsules) and as food for medical purposes ... A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory ... In Italy and Spain (300 mg and 600 mg tablets). …

Bromochlorosalicylanilide

Experimental
Matched Categories: … Antifungals for Topical Use ... Antifungals for Dermatological Use …

Biropepimut-S

Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity).
Investigational
Matched Description: … Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 ... (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity …

Amiselimod

Experimental

alpha-Pyrrolidinononanophenone

Investigational
Displaying drugs 7026 - 7050 of 13643 in total